BHCM
AUPH icon

Brevan Howard Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Brevan Howard Capital Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$420K Buy
24,770
+911
+4% +$14.6K ﹤0.01% 1527
2026
Q1 		$354K Buy
23,859
+11,971
+101% +$175K ﹤0.01% 1520
2025
Q4 		$190K Buy
+11,888
New +$169K ﹤0.01% 1597
2025
Q3 		– Sell
-30,847
Closed -$261K – 1934
2025
Q2 		$261K Buy
+30,847
New +$247K ﹤0.01% 1602

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brevan Howard Capital Management's AUPH Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Aurinia Pharmaceuticals (AUPH) stake by 3.8% in Q2 2026, buying an estimated $14.6K and bringing the position to 24,770 shares worth $420K. The position accounts for ﹤0.01% of the portfolio, ranked #1527.

Brevan Howard Capital Management first reported a position in AUPH in Q2 2025 and has held it in 4 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Brevan Howard Capital Management held 24,770 shares of Aurinia Pharmaceuticals worth $420K as of Q2 2026.
  • Brevan Howard Capital Management bought 911 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $14.6K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1527 holding.
  • Brevan Howard Capital Management first reported a position in Aurinia Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.